BioRestorative Therapies (BRTX) Short Interest Ratio & Short Volume

Short interest is the volume of BioRestorative Therapies shares that have been sold short but have not yet been closed out or covered. As of October 15th, traders have sold 26,100 shares of BRTX short. Learn More on BioRestorative Therapies' current short interest.

BioRestorative Therapies saw a increase in short interest during the month of October. As of October 15th, there was short interest totaling 26,100 shares, an increase of 2,510.0% from the previous total of 1,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "healthcare" compare to BioRestorative Therapies: OpGen, Inc. (0.02%), P3 Health Partners Inc. (1.70%), Biodesix, Inc. (4.79%), Burning Rock Biotech Limited Sponsored ADR (0.45%), Cryo-Cell International Inc. (0.20%), Concord Medical Services Holdings Limited (0.06%), PharmChem Inc. (0.03%), Enzo Biochem, Inc. (0.97%), American Shared Hospital Services (1.48%), BioNexus Gene Lab Corp. (0.71%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Advanced Micro Devices, Inc. ($7.75 billion), S&P Global Inc. ($7.73 billion), Charter Communications, Inc. ($5.40 billion), Snowflake Inc. ($4.50 billion), Canadian Pacific Kansas City Limited ($4.39 billion), Uber Technologies, Inc. ($4.21 billion), Wayfair Inc. ($4.15 billion), Palo Alto Networks, Inc. ($3.27 billion), Teladoc Health, Inc. ($2.78 billion), and DoorDash, Inc. ($2.62 billion). View all of the most shorted stocks.

Short selling BRTX is an investing strategy that aims to generate trading profit from BioRestorative Therapies as its price is falling. BRTX shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for BioRestorative Therapies occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BRTX, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BRTX, twice per month. The most recent reporting period available is October, 15 2021.